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Abstract Body weight regulation is a complex pheno-
type also depending on the action of uncoupling proteins
(UCPs) that mediate the “uncoupling” of respiration
leading to the dissipation of energy as heat. This study
investigated whether genetic variants in the genes encod-
ing UCP-1 and UCP-3 are associated with different obe-
sity-related phenotypes in 162 whites with a wide range
of body mass index. All subjects were genotyped for the
polymorphisms UCP-1 A-3826G, UCP-1 Ala64Thr, and
UCP-3 C-55T using a PCR-based restriction method
with appropriate enzymes. The frequencies of the UCP-1
3826G, UCP-1 64Thr, and UCP-3 55T alleles were
27.2%, 12.0%, and 22.8%, respectively. No significant
associations were observed between polymorphism and
body mass index or obesity. However, after adjustment
for gender, age, body mass index, and diabetes mellitus
the waist-to-hip ratio was significantly associated with
UCP-1 Ala64Thr (P=0.003) and UCP-3 C-55T (P=0.02)
but not with UCP-1 A-3826G. The higher waist-to-hip
ratios associated with the UCP-1 64Thr and UCP-3 55T
alleles were due to higher waist circumference in these
allele carriers. In conclusion, central obesity in whites as
reflected by an increased waist-to-hip ratio is associated
with the UCP-1 Ala64Thr and UCP-3 C-55T polymor-
phisms. To what extent these genotypes contribute to the
overall cardiovascular risk remains to be elucidated.
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Introduction
Body weight is tightly regulated by the balance between
energy intake and expenditure. Energy expenditure itself
is a complex trait including the metabolic rate at rest and
depends on basal metabolism and exercise-induced and
adaptive thermogenesis [1]. Low rate of energy expendi-
ture has been shown to increase the risk of developing
obesity [2]. In addition to environmental factors, life-
style, and the quantity and quality of food intake, there
are genetic factors that modulate the balance between en-
ergy intake and expenditure [3, 4].
Uncoupling proteins (UCPs) are mitochondrial mem-
brane transporters that mediate the “uncoupling” of res-
piration leading to the dissipation of energy as heat [5].
UCPs may increase energy expenditure and thereby de-
crease body weight. Five members of the UCP gene
family, termed UCP-1 to UCP-5, have so far been iden-
tified in humans [6, 7], all of which exhibit structural
homology and share functional properties. Whereas
UCP-1 is expressed only in brown adipose tissue [5],
UCP-3 is expressed in both human skeletal muscle and
brown adipose tissue [8]. Several human tissues includ-
ing brown and white adipose tissue, lung, liver, spleen,
and macrophages express UCP-2 [9]. The UCP-1 gene
resides on chromosome 4q31 [10], and the UCP-2 and
UCP-3 genes constitute a cluster mapping to 11q13 [11].
Genetic polymorphisms in these three UCP genes have
been variably associated with metabolic and obesity-re-
lated phenotypes. Since genetic studies on the impact of
UCP-2 polymorphisms on obesity appear less convinc-
ing [12, 13, 14, 15], we investigated whether known
variants in UCP-1 (A-3826G, Ala64Thr) and UCP-3 
(C-55T) genes are associated with obesity-related phe-
notypes in a well characterized study population of
white subjects.
Materials and methods
Subjects
The study enrolled 162 unrelated white subjects (45 men; 117
women) with a wide range of body mass index (BMI; range
20.2–54.9 kg/m2), with and without hypertension and/or impaired
glucose tolerance, who responded to an advertisement on the uni-
versity campus of the Benjamin Franklin Medical Center in Berlin.
Men and women had similar age (52.9±9.9 years), BMI
(32.0±6.4 kg/m2), hip circumference (110.7±14.2 cm), and post-
prandial thermogenesis (241±90 kJ/day). Other phenotypic mea-
surements such as waist-to-hip ratio were significantly higher in
men than in women except for percentage body fat, fat mass, 
and fasting plasma leptin levels, which were all higher in women
(Table 1). Patients with congestive heart failure, abnormal renal or
liver function, and intentional weight reduction during the preced-
ing 3 months were excluded. Patients were also assessed for the in-
take of thyroid hormones and other medications. Obesity was de-
fined as BMI of 30 kg/m2 or higher [16]. All subjects were charac-
terized for weight, height, waist and hip circumferences. Body
composition was determined by bioelectrical impedance analysis
(Akern-RJL BIA 101/S, Frankfurt, Germany) [17]. Subjects were
subsequently asked to record their daily intake of foods using a 
7-day weighed dietary record. The study protocol was approved by
the local institutional ethics committee, and all subjects gave in-
formed consent.
Measurement of energy expenditure
For the measurement of energy expenditure subjects were admit-
ted to a metabolic ward in the evening before the test. They were
given a light evening snack. After a 12-h overnight fast the resting
metabolic rate was measured in the sitting awake subject in a tem-
perature-controlled room over two 25-min periods with an open-
circuit indirect calorimetric system (standardized for temperature,
pressure and moisture) fitted with a face mask (Sensor Medics
2900 Z, NewMedics Medizinelektronik, Öhringen, Germany).
Complete urine samples were collected during the measurement of
energy expenditure for the assessment of nitrogen excretion to de-
termine the basal substrate oxidation. From each measurement the
first 5-min period was discarded. Data from the remaining 20 min
were averaged and used to calculate energy expenditure and sub-
strate oxidation based on oxygen consumption, carbon dioxide
production, and urinary nitrogen excretion [18, 19].
Genotyping
Genomic DNA was prepared from peripheral blood using a DNA-
selective preparation method (Qiagen, Hilden, Germany). The re-
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Table 1 Characteristics of the
study population: arithmetic
means ±SD or geometric
means (95% confidence inter-
val)
Men (n=45) Women (n=117) P
Age (years) 53.3±10.7 52.8±9.6 0.76
Body weight (kg) 101.2±19.3 84.7±17.6 <0.0001
Body height (cm) 177.1±7.0 162.9±6.7 <0.0001
Body mass index (kg/m2) 32.2±6.3 31.9±6.5 0.81
Waist circumference (cm) 110.6±16.4 99.6±15.3 <0.0001
Hip circumference (cm) 112.0±14.3 110.2±14.2 0.48
Waist-to-hip ratio 0.986±0.040 0.902±0.048 <0.0001
Body fat (%) 25.9±6.7 36.6±5.3 <0.0001
Fat mass (kg) 26.8±11.1 31.7±10.3 0.01
Fat-free mass (kg) 73.7±11.3 52.9±8.6 <0.0001
Resting metabolic rate (kJ/day) 7957±1210 6296±911 <0.0001
Postprandial thermogenesis (kJ/day) 255±93 235±88 0.20
Fasting plasma leptin (ng/ml) 8.9 (7.3–10.9) 23.0 (20.4–26.1) <0.0001
Fasting plasma insulin (mU/l) 22.7 (18.7–27.4) 14.7 (13.0–16.6) 0.002
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gions encompassing the three different polymorphic sites were
amplified by polymerase chain reaction as previously described
[20, 21, 22]. Polymerase chain reaction products were digested 
using the restriction enzymes BclI, MspA1, and BseDI, for the
polymorphisms UCP-1 A-3826G, UCP-1 Ala64Thr, and UCP-3
C-55T, respectively, and finally visualized on UV-transilluminated
ethidium bromide-stained agarose gels.
Statistical analysis
We used SAS version 8.1 (SAS Institute, Cary, N.C., USA) for
database management and statistical analysis. Measurements with
a skewed distribution were normalized by logarithmic transforma-
tion. Comparisons of means and proportions were performed with
the standard normal Z-test and Fisher’s exact test, respectively. We
employed analysis of covariance to compare adjusted continuous
measurements between genotypes.
Results
UCP-1 and UCP-3 polymorphisms are associated 
with waist-to-hip ratio
The genotype distributions for UCP-1 A-3826G (AA
0.51, AG 0.44, GG 0.05; P=0.12) and UCP-3 C-55T (CC
0.58, CT 0.38, TT 0.04; P=0.27) were in Hardy-Wein-
berg equilibrium, which was not the case for UCP-1
Ala64Thr, regardless of gender, and the presence of obe-
sity or diabetes mellitus. UCP-1 A-3826G and Ala64Thr
displayed significant linkage disequilibrium with one an-
other (P<0.0001). Genotype and allele frequencies did
not differ between obese and nonobese subjects for any
of the three polymorphisms investigated in the whole
study population (P>0.32; Table 2).
No significant association was observed between the
three genetic polymorphisms and BMI, resting metabolic
rate, postprandial thermogenesis, or fasting plasma leptin
and insulin levels. However, after adjustment for gender,
age, BMI, and the presence of diabetes mellitus the
waist-to-hip ratio was significantly associated with UCP-1
Ala64Thr (means: AlaAla 0.920, AlaThr 0.946, ThrThr
0.953; P=0.003) and UCP-3 C-55T (CC 0.920, CT
0.928, TT 0.966; P=0.02; Fig. 1), but not with UCP-1 
A-3826G (AA 0.919, AG 0.931, GG 0.933; P=0.15).
The associations between the waist-to-hip ratio and
UCP-1 Ala64Thr and UCP-3 C-55T were due to the 
increased waist circumference in carriers of the UCP-1
64Thr allele (AlaThr and ThrThr 105.2 vs. AlaAla
102.2 cm, P=0.01; Table 3) and UCP-3 55T allele (CT
and TT 103.6 vs. CC 101.9 cm, P=0.06).
In models comparing carriers of the UCP-1 3826G 
allele with UCP-1 3826A homozygotes, UCP-1 3826G
allele carriers had a slightly higher waist-to-hip ratio
(P=0.05; Table 3). However, when both UCP-1 variants
were included in a single model, the difference in the
waist-to-hip ratio between UCP-1 3826A homozygotes
and G allele carries became nonsignificant (0.932 vs.
0.936; P=0.59), whereas the effect of the UCP-1
Ala64Thr polymorphism remained unaltered (0.921 vs.
0.948; P=0.004). These results suggest that the slightly
higher waist-to-hip ratio in UCP-1 3826G allele carriers
was actually due to linkage disequilibrium with the
Ala64Thr variant.
Table 2 Genotype frequencies
for UCP-1 and UCP-3 poly-
morphisms; obesity defined as
BMI ≥30 kg/m2
a P values based on Fisher’s 
exact test for the comparison
between obese and nonobese
Genotype frequency (n) Pa
UCP-1 A-3826G AA AG GG 0.90
Nonobese (n=69) 50.7% (35) 43.5% (30) 5.8% (4)
Obese (n=93) 50.5% (47) 45.2% (42) 4.3% (4)
UCP-1 Ala64Thr AlaAla AlaThr ThrThr 0.32
Nonobese (n=69) 84.1% (58) 4.3% (3) 11.6% (8)
Obese (n=93) 84.9% (79) 8.6% (8) 6.5% (6)
UCP-3 C-55T CC CT TT 0.66
Nonobese (n=69) 55.1% (38) 42.0% (29) 2.9% (2)
Obese (n=93) 60.2% (56) 35.5% (33) 4.3% (4)
Fig. 1 Association between waist-to-hip ratio and UCP-1
Ala64Thr and UCP-3 C-55T polymorphisms. Squares Means ad-
justed for gender, age, BMI, and diabetes mellitus; vertical lines
SEs. P values were based on analysis of variance; n the number of
subjects by genotype
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We additionally performed a gender-specific analysis
of the waist-to-hip ratio in relation to the UCP-1
Ala64Thr and UCP-3 C-55T polymorphisms. In 117
women the waist-to-hip ratio was significantly related to
UCP-1 Ala64Thr (P=0.002) but was only weakly associ-
ated with UCP-3 C-55T (P=0.08). In 45 men these effect
sizes were similar to those in women, but due to the
smaller sample size these associations did not reach sta-
tistical significance (P=0.23 and 0.59, respectively).
Discussion
The main result of the present study is the significant
association between the waist-to-hip ratio and the 
UCP-1 Ala64Thr and UCP-3 C-55T polymorphisms.
When considering UCP-1 A-3826G alone, a weak asso-
ciation with waist-to-hip ratio was observed, which may
possibly be explained by linkage disequilibrium with
UCP-1 Ala64Thr.
None of the investigated polymorphisms was associ-
ated with BMI as continuous variable or obesity as a di-
chotomous trait. A possible explanation is that abdomi-
nal obesity, a phenotype of visceral fat distribution mea-
sured by the waist-to-hip ratio [23], is more specific than
BMI, which reflects overall obesity. Central obesity has
been shown to be a better predictor of coronary events in
high-risk populations than overall obesity [24]. The large
prospective Atherosclerosis Risk in Communities Study
[25] found the waist-to-hip ratio and not BMI to be a risk
factor for incident coronary heart disease. Another study
[26] reported that a waist-to-hip ratio of 0.91 or more
was associated with a nearly threefold increased risk of
acute coronary events, and provided additional prognos-
tic information beyond BMI. Interestingly, BMI did not
add to the predictive value of the waist-to-hip ratio in
predicting these coronary events. Along similar lines, a
prospective hospital-based case-control study of first
myocardial infarction showed that in Indians the most
predictive independent variables for acute coronary
events were smoking and the waist-to-hip ratio [27].
From a genetic point of view Jee et al. [28] investigat-
ed environmental and genetic influences on waist cir-
cumference and waist-to-hip ratio in 2,507 members of
435 Korean families. Segregation analysis provided evi-
dence of a major gene controlling waist circumference in
these families. In line with the present findings, several
other reports on various genetic polymorphisms have
also suggested an association with abdominal fat but not
with overall obesity. This indicates that genotype-pheno-
type associations differ in central obesity and overall
obesity [29, 30]. More specifically, Perusse et al. [31]
performed a genome-wide scan for different abdominal
fat phenotypes (abdominal total fat, abdominal visceral
fat, abdominal subcutaneous fat) assessed by computed
tomography in the Québec Family Study and identified
several chromosomal loci harboring genes affecting the
propensity to store abdominal fat.
After weight reduction or during prolonged weight
loss the UCP-3 mRNA expression decreases in obese in-
dividuals. This observation suggests that reduced UCP-3
expression contributes to the decreased energy expendi-
ture [32, 33]. Independent studies report linkage of the
resting metabolic rate and other obesity-related pheno-
types to markers at the UCP-2/UCP-3 locus [11, 34]. In-
terestingly, this region is syntenic to a region of mouse
chromosome 7, which is also linked to obesity as well as
to a region of rat chromosome 1, which is linked to glu-
cose intolerance and adiposity in a rat model of type 2
diabetes mellitus [9, 35].
Although some association studies on the impact of
UCP-1 polymorphisms on metabolic phenotypes were
inconclusive [36, 37, 38], other investigators have ob-
served associations of UCP-1 variants with weight gain
and resistance to weight loss [21, 39, 40]. Only a few
studies have investigated UCP-1 Ala64Thr in relation to
obesity or related phenotypes [20]. The latter study con-
ducted among children and adolescents found that the
64Thr allele was more frequent in obese subjects than in
a lean controls. However, correction for multiple testing
removed the statistical significance. Thus the functional
impact of this substitution remains unclear.
With respect to the UCP-3 gene polymorphisms some
studies indicate a role for UCP-3 in energy expenditure
in humans [22, 41]. More specifically, and in agreement
with our present findings, Cassell et al. [42] reported a
Table 3 Associations between obesity-related phenotypes and the
UCP-1 A-3826G and Ala64Thr polymorphisms. All analyses ad-
justed for gender, age, and the presence of diabetes mellitus;
waist-to-hip ratio, waist circumference, and fasting plasma leptin
and insulin levels also adjusted for BMI; resting metabolic rate
also adjusted for fat-free mass and body fat
UCP-1 A-3826G UCP-1 Ala64Thr
AA AG+GG P AlaAla AlaThr+ThrThr P
Body-mass index (kg/m2) 31.9±0.7 32.1±0.7 0.81 31.9±0.5 32.3±1.3 0.83
Waist-to-hip ratio 0.919±0.004 0.931±0.004 0.05 0.920±0.003 0.950±0.008 0.0006
Waist circumference (cm) 101.9±0.6 103.4±0.6 0.09 102.2±0.5 105.2±1.1 0.01
Resting metabolic rate (kJ/day) 6705±66 6785±68 0.41 6730±51 6821±119 0.49
Postprandial thermogenesis (kJ/day) 246±10 235±11 0.43 240±8 245±18 0.79
Fasting plasma leptin (ng/ml) 17.7 (16.1−19.4) 17.7 (16.1−19.5) 0.95 17.8 (16.6−19.2) 17.0 (14.4−20.1) 0.62
Fasting plasma insulin (mU/l) 16.4 (14.5−18.5) 16.9 (14.9−19.2) 0.72 17.1 (15.5−18.8) 14.7 (11.8−18.3) 0.22
consistent association between the UCP-3 55T allele and
increased waist-to-hip ratio in women from three sepa-
rate data sets. Interestingly, the C-55T polymorphism is
situated in close vicinity to a putative TATA-box as well
as a retinoic acid responsive element [43], indicating a
potential functionality of the variant. Even when the nu-
cleotide change does not directly involve a consensus
site, it may alter the secondary DNA structure around
these sequence elements affecting the access of tran-
scription factors [44].
The present findings should be interpreted within the
context of its limitations. Our study population is well
characterized but relatively small, and a large proportion
of subjects were obese or overweight. Therefore our
findings can probably not be extrapolated to the general
population. The observed associations, although highly
significant, require further confirmation in larger groups
of subjects.
In conclusion, central obesity in whites as reflected
by an increased waist-to-hip ratio is associated with the
UCP-1 Ala64Thr and UCP-3 C-55T polymorphisms. To
what extent these genotypes contribute to the overall car-
diovascular risk remains to be elucidated.
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